Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $171.94 USD
Change Today +3.37 / 2.00%
Volume 2.6M
ALXN On Other Exchanges
As of 8:10 PM 05/22/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Stephen P. Squinto Ph.D.

AgeTotal Calculated CompensationThis person is connected to 8 board members in 1 different organizations across 2 different industries.

See Board Relationships
As of Fiscal Year 2014


Dr. Stephen P. Squinto, also known as Steve, Ph.D., serves as a Venture Partner at OrbiMed. Dr. Squinto co-founded Alexion Pharmaceuticals, Inc. in 1992 and served as its Executive Vice President since August 2000 until January 1, 2015 and Chief Global Operations Officer since May 2013 until January 1, 2015. He served as Head of Research and Development at Alexion Pharmaceuticals Inc. since June 2007 until 2013. He served as the Head of Research at Alexion Pharmaceuticals, ...

Read Full Background

Corporate Headquarters*

352 Knotter Drive
Cheshire, Connecticut 06410

United States

Phone: 203-272-2596
Fax: 203-271-8198

Board Members Memberships*



Loyola University of Chicago
Loyola University of Chicago

Other Affiliations*

Annual Compensation*

Total Annual Compensation$710,000

Stock Options*

Restricted Stock Awards$3,711,397
All Other Compensation$23,000
Exercised Options48,114
Exercised Options Value$5,030,348
Exercisable Options89,134
Exercisable Options Value$6,966,230
Total Value of Options$11,996,577
Total Number of Options137,248

Total Compensation*

Total Annual Cash Compensation$1,178,000
Total Short Term Compensation$710,000
Other Long Term Compensation$3,734,397
Total Calculated Compensation$9,963,844
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ALXN:US $171.94 USD +3.37


Robert W. Duggan Chairman and Chief Executive Officer
Pharmacyclics Inc.
Rakesh Sachdev Chief Executive Officer, President and Director
Sigma-Aldrich Corporation
Heinz-Jurgen Bertram Ph.D.Chairman of Executive Board, Chief Executive Officer and Labour Director
Symrise AG
Gunupati Venkateswara Prasad B.Sc. (Chem. Eng.), M.S. (Indl. Admn.)Co-Chairman, Chief Executive Officer, Member of The Management Council, Director, Member of Management Committee, Member of Stakeholders' Relationship Committee, Member of Investment Committee and Member of Corporate Social Responsibility Committee
Dr. Reddy's Laboratories Ltd.
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ALEXION PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at